Medical Care
Global Parkinson's Disease Therapeutics Market Research Report 2025
- Mar 11, 25
- ID: 12125
- Pages: 97
- Figures: 93
- Views: 36
The global market for Parkinson's Disease Therapeutics was valued at US$ 2641 million in the year 2024 and is projected to reach a revised size of US$ 3948 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Parkinson"s disease (PD), or simply Parkinson"s, is a chronic degenerative disorder of the central nervous system that affects both the motor system and non-motor systems. The symptoms usually emerge slowly, and as the disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson"s disease dementia becomes common in advanced stages of the disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Parkinson's Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson's Disease Therapeutics.
The Parkinson's Disease Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Parkinson's Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parkinson's Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Roche
H.Lundbeck
Bausch Health
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Desitin Arzneimittel
Endo Pharmaceuticals
Segment by Type
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
Segment by Application
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parkinson's Disease Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Parkinson"s disease (PD), or simply Parkinson"s, is a chronic degenerative disorder of the central nervous system that affects both the motor system and non-motor systems. The symptoms usually emerge slowly, and as the disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson"s disease dementia becomes common in advanced stages of the disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Parkinson's Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson's Disease Therapeutics.
The Parkinson's Disease Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Parkinson's Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parkinson's Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Roche
H.Lundbeck
Bausch Health
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Desitin Arzneimittel
Endo Pharmaceuticals
Segment by Type
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
Segment by Application
Under 40 Years Old
40-65 Years Old
Above 65 Years Old
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parkinson's Disease Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Market by Application
1.3.1 Global Parkinson's Disease Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease Therapeutics Market Perspective (2020-2031)
2.2 Global Parkinson's Disease Therapeutics Growth Trends by Region
2.2.1 Global Parkinson's Disease Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Parkinson's Disease Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Parkinson's Disease Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Parkinson's Disease Therapeutics Market Dynamics
2.3.1 Parkinson's Disease Therapeutics Industry Trends
2.3.2 Parkinson's Disease Therapeutics Market Drivers
2.3.3 Parkinson's Disease Therapeutics Market Challenges
2.3.4 Parkinson's Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson's Disease Therapeutics Players by Revenue
3.1.1 Global Top Parkinson's Disease Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Parkinson's Disease Therapeutics Revenue
3.4 Global Parkinson's Disease Therapeutics Market Concentration Ratio
3.4.1 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Therapeutics Revenue in 2024
3.5 Global Key Players of Parkinson's Disease Therapeutics Head office and Area Served
3.6 Global Key Players of Parkinson's Disease Therapeutics, Product and Application
3.7 Global Key Players of Parkinson's Disease Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Therapeutics Breakdown Data by Type
4.1 Global Parkinson's Disease Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2026-2031)
5 Parkinson's Disease Therapeutics Breakdown Data by Application
5.1 Global Parkinson's Disease Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Parkinson's Disease Therapeutics Market Size (2020-2031)
6.2 North America Parkinson's Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Parkinson's Disease Therapeutics Market Size by Country (2020-2025)
6.4 North America Parkinson's Disease Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Parkinson's Disease Therapeutics Market Size (2020-2031)
7.2 Europe Parkinson's Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Parkinson's Disease Therapeutics Market Size by Country (2020-2025)
7.4 Europe Parkinson's Disease Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Parkinson's Disease Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Parkinson's Disease Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Parkinson's Disease Therapeutics Market Size (2020-2031)
9.2 Latin America Parkinson's Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Parkinson's Disease Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Parkinson's Disease Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Parkinson's Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Parkinson's Disease Therapeutics Introduction
11.1.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Akorn
11.2.1 Akorn Company Details
11.2.2 Akorn Business Overview
11.2.3 Akorn Parkinson's Disease Therapeutics Introduction
11.2.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.2.5 Akorn Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson's Disease Therapeutics Introduction
11.3.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Parkinson's Disease Therapeutics Introduction
11.4.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Details
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Introduction
11.6.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.6.5 Teva Pharmaceutical Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson's Disease Therapeutics Introduction
11.7.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.7.5 Abbvie Recent Development
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Details
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.8.5 Kyowa Hakko Kirin Pharma Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson's Disease Therapeutics Introduction
11.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.9.5 Astellas Pharma Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Parkinson's Disease Therapeutics Introduction
11.10.4 Roche Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.10.5 Roche Recent Development
11.11 H.Lundbeck
11.11.1 H.Lundbeck Company Details
11.11.2 H.Lundbeck Business Overview
11.11.3 H.Lundbeck Parkinson's Disease Therapeutics Introduction
11.11.4 H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.11.5 H.Lundbeck Recent Development
11.12 Bausch Health
11.12.1 Bausch Health Company Details
11.12.2 Bausch Health Business Overview
11.12.3 Bausch Health Parkinson's Disease Therapeutics Introduction
11.12.4 Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.12.5 Bausch Health Recent Development
11.13 Apokyn
11.13.1 Apokyn Company Details
11.13.2 Apokyn Business Overview
11.13.3 Apokyn Parkinson's Disease Therapeutics Introduction
11.13.4 Apokyn Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.13.5 Apokyn Recent Development
11.14 Orion
11.14.1 Orion Company Details
11.14.2 Orion Business Overview
11.14.3 Orion Parkinson's Disease Therapeutics Introduction
11.14.4 Orion Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.14.5 Orion Recent Development
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Details
11.15.2 Stada Arzneimittel Business Overview
11.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Introduction
11.15.4 Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.15.5 Stada Arzneimittel Recent Development
11.16 US WorldMeds
11.16.1 US WorldMeds Company Details
11.16.2 US WorldMeds Business Overview
11.16.3 US WorldMeds Parkinson's Disease Therapeutics Introduction
11.16.4 US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.16.5 US WorldMeds Recent Development
11.17 Desitin Arzneimittel
11.17.1 Desitin Arzneimittel Company Details
11.17.2 Desitin Arzneimittel Business Overview
11.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Introduction
11.17.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.17.5 Desitin Arzneimittel Recent Development
11.18 Endo Pharmaceuticals
11.18.1 Endo Pharmaceuticals Company Details
11.18.2 Endo Pharmaceuticals Business Overview
11.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Introduction
11.18.4 Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.18.5 Endo Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Market by Application
1.3.1 Global Parkinson's Disease Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease Therapeutics Market Perspective (2020-2031)
2.2 Global Parkinson's Disease Therapeutics Growth Trends by Region
2.2.1 Global Parkinson's Disease Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Parkinson's Disease Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Parkinson's Disease Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Parkinson's Disease Therapeutics Market Dynamics
2.3.1 Parkinson's Disease Therapeutics Industry Trends
2.3.2 Parkinson's Disease Therapeutics Market Drivers
2.3.3 Parkinson's Disease Therapeutics Market Challenges
2.3.4 Parkinson's Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson's Disease Therapeutics Players by Revenue
3.1.1 Global Top Parkinson's Disease Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Parkinson's Disease Therapeutics Revenue
3.4 Global Parkinson's Disease Therapeutics Market Concentration Ratio
3.4.1 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Therapeutics Revenue in 2024
3.5 Global Key Players of Parkinson's Disease Therapeutics Head office and Area Served
3.6 Global Key Players of Parkinson's Disease Therapeutics, Product and Application
3.7 Global Key Players of Parkinson's Disease Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Therapeutics Breakdown Data by Type
4.1 Global Parkinson's Disease Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2026-2031)
5 Parkinson's Disease Therapeutics Breakdown Data by Application
5.1 Global Parkinson's Disease Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Parkinson's Disease Therapeutics Market Size (2020-2031)
6.2 North America Parkinson's Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Parkinson's Disease Therapeutics Market Size by Country (2020-2025)
6.4 North America Parkinson's Disease Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Parkinson's Disease Therapeutics Market Size (2020-2031)
7.2 Europe Parkinson's Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Parkinson's Disease Therapeutics Market Size by Country (2020-2025)
7.4 Europe Parkinson's Disease Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Parkinson's Disease Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Parkinson's Disease Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Parkinson's Disease Therapeutics Market Size (2020-2031)
9.2 Latin America Parkinson's Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Parkinson's Disease Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Parkinson's Disease Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Parkinson's Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Parkinson's Disease Therapeutics Introduction
11.1.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Akorn
11.2.1 Akorn Company Details
11.2.2 Akorn Business Overview
11.2.3 Akorn Parkinson's Disease Therapeutics Introduction
11.2.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.2.5 Akorn Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson's Disease Therapeutics Introduction
11.3.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Parkinson's Disease Therapeutics Introduction
11.4.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Details
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Introduction
11.6.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.6.5 Teva Pharmaceutical Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson's Disease Therapeutics Introduction
11.7.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.7.5 Abbvie Recent Development
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Details
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.8.5 Kyowa Hakko Kirin Pharma Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson's Disease Therapeutics Introduction
11.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.9.5 Astellas Pharma Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Parkinson's Disease Therapeutics Introduction
11.10.4 Roche Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.10.5 Roche Recent Development
11.11 H.Lundbeck
11.11.1 H.Lundbeck Company Details
11.11.2 H.Lundbeck Business Overview
11.11.3 H.Lundbeck Parkinson's Disease Therapeutics Introduction
11.11.4 H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.11.5 H.Lundbeck Recent Development
11.12 Bausch Health
11.12.1 Bausch Health Company Details
11.12.2 Bausch Health Business Overview
11.12.3 Bausch Health Parkinson's Disease Therapeutics Introduction
11.12.4 Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.12.5 Bausch Health Recent Development
11.13 Apokyn
11.13.1 Apokyn Company Details
11.13.2 Apokyn Business Overview
11.13.3 Apokyn Parkinson's Disease Therapeutics Introduction
11.13.4 Apokyn Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.13.5 Apokyn Recent Development
11.14 Orion
11.14.1 Orion Company Details
11.14.2 Orion Business Overview
11.14.3 Orion Parkinson's Disease Therapeutics Introduction
11.14.4 Orion Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.14.5 Orion Recent Development
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Details
11.15.2 Stada Arzneimittel Business Overview
11.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Introduction
11.15.4 Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.15.5 Stada Arzneimittel Recent Development
11.16 US WorldMeds
11.16.1 US WorldMeds Company Details
11.16.2 US WorldMeds Business Overview
11.16.3 US WorldMeds Parkinson's Disease Therapeutics Introduction
11.16.4 US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.16.5 US WorldMeds Recent Development
11.17 Desitin Arzneimittel
11.17.1 Desitin Arzneimittel Company Details
11.17.2 Desitin Arzneimittel Business Overview
11.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Introduction
11.17.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.17.5 Desitin Arzneimittel Recent Development
11.18 Endo Pharmaceuticals
11.18.1 Endo Pharmaceuticals Company Details
11.18.2 Endo Pharmaceuticals Business Overview
11.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Introduction
11.18.4 Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2020-2025)
11.18.5 Endo Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Sinemet-CR
Table 3. Key Players of Trastal
Table 4. Key Players of Madopar
Table 5. Key Players of COMT Inhibitor
Table 6. Key Players of Other
Table 7. Global Parkinson's Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Parkinson's Disease Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Parkinson's Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Parkinson's Disease Therapeutics Market Share by Region (2020-2025)
Table 11. Global Parkinson's Disease Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Parkinson's Disease Therapeutics Market Share by Region (2026-2031)
Table 13. Parkinson's Disease Therapeutics Market Trends
Table 14. Parkinson's Disease Therapeutics Market Drivers
Table 15. Parkinson's Disease Therapeutics Market Challenges
Table 16. Parkinson's Disease Therapeutics Market Restraints
Table 17. Global Parkinson's Disease Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Parkinson's Disease Therapeutics Market Share by Players (2020-2025)
Table 19. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2024)
Table 20. Ranking of Global Top Parkinson's Disease Therapeutics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Parkinson's Disease Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Parkinson's Disease Therapeutics, Headquarters and Area Served
Table 23. Global Key Players of Parkinson's Disease Therapeutics, Product and Application
Table 24. Global Key Players of Parkinson's Disease Therapeutics, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Parkinson's Disease Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2020-2025)
Table 28. Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2026-2031)
Table 30. Global Parkinson's Disease Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2020-2025)
Table 32. Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2026-2031)
Table 34. North America Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Parkinson's Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Parkinson's Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Parkinson's Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Parkinson's Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 49. Merck Company Details
Table 50. Merck Business Overview
Table 51. Merck Parkinson's Disease Therapeutics Product
Table 52. Merck Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 53. Merck Recent Development
Table 54. Akorn Company Details
Table 55. Akorn Business Overview
Table 56. Akorn Parkinson's Disease Therapeutics Product
Table 57. Akorn Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 58. Akorn Recent Development
Table 59. GSK Company Details
Table 60. GSK Business Overview
Table 61. GSK Parkinson's Disease Therapeutics Product
Table 62. GSK Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 63. GSK Recent Development
Table 64. Novartis Company Details
Table 65. Novartis Business Overview
Table 66. Novartis Parkinson's Disease Therapeutics Product
Table 67. Novartis Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Boehringer Ingelheim Company Details
Table 70. Boehringer Ingelheim Business Overview
Table 71. Boehringer Ingelheim Parkinson's Disease Therapeutics Product
Table 72. Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 73. Boehringer Ingelheim Recent Development
Table 74. Teva Pharmaceutical Company Details
Table 75. Teva Pharmaceutical Business Overview
Table 76. Teva Pharmaceutical Parkinson's Disease Therapeutics Product
Table 77. Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 78. Teva Pharmaceutical Recent Development
Table 79. Abbvie Company Details
Table 80. Abbvie Business Overview
Table 81. Abbvie Parkinson's Disease Therapeutics Product
Table 82. Abbvie Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 83. Abbvie Recent Development
Table 84. Kyowa Hakko Kirin Pharma Company Details
Table 85. Kyowa Hakko Kirin Pharma Business Overview
Table 86. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product
Table 87. Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 88. Kyowa Hakko Kirin Pharma Recent Development
Table 89. Astellas Pharma Company Details
Table 90. Astellas Pharma Business Overview
Table 91. Astellas Pharma Parkinson's Disease Therapeutics Product
Table 92. Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 93. Astellas Pharma Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Parkinson's Disease Therapeutics Product
Table 97. Roche Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 98. Roche Recent Development
Table 99. H.Lundbeck Company Details
Table 100. H.Lundbeck Business Overview
Table 101. H.Lundbeck Parkinson's Disease Therapeutics Product
Table 102. H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 103. H.Lundbeck Recent Development
Table 104. Bausch Health Company Details
Table 105. Bausch Health Business Overview
Table 106. Bausch Health Parkinson's Disease Therapeutics Product
Table 107. Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 108. Bausch Health Recent Development
Table 109. Apokyn Company Details
Table 110. Apokyn Business Overview
Table 111. Apokyn Parkinson's Disease Therapeutics Product
Table 112. Apokyn Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 113. Apokyn Recent Development
Table 114. Orion Company Details
Table 115. Orion Business Overview
Table 116. Orion Parkinson's Disease Therapeutics Product
Table 117. Orion Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 118. Orion Recent Development
Table 119. Stada Arzneimittel Company Details
Table 120. Stada Arzneimittel Business Overview
Table 121. Stada Arzneimittel Parkinson's Disease Therapeutics Product
Table 122. Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 123. Stada Arzneimittel Recent Development
Table 124. US WorldMeds Company Details
Table 125. US WorldMeds Business Overview
Table 126. US WorldMeds Parkinson's Disease Therapeutics Product
Table 127. US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 128. US WorldMeds Recent Development
Table 129. Desitin Arzneimittel Company Details
Table 130. Desitin Arzneimittel Business Overview
Table 131. Desitin Arzneimittel Parkinson's Disease Therapeutics Product
Table 132. Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 133. Desitin Arzneimittel Recent Development
Table 134. Endo Pharmaceuticals Company Details
Table 135. Endo Pharmaceuticals Business Overview
Table 136. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product
Table 137. Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 138. Endo Pharmaceuticals Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. Authors List of This Report
List of Figures
Figure 1. Parkinson's Disease Therapeutics Picture
Figure 2. Global Parkinson's Disease Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Parkinson's Disease Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Sinemet-CR Features
Figure 5. Trastal Features
Figure 6. Madopar Features
Figure 7. COMT Inhibitor Features
Figure 8. Other Features
Figure 9. Global Parkinson's Disease Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Parkinson's Disease Therapeutics Market Share by Application: 2024 VS 2031
Figure 11. Under 40 Years Old Case Studies
Figure 12. 40-65 Years Old Case Studies
Figure 13. Above 65 Years Old Case Studies
Figure 14. Parkinson's Disease Therapeutics Report Years Considered
Figure 15. Global Parkinson's Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Parkinson's Disease Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Parkinson's Disease Therapeutics Market Share by Region: 2024 VS 2031
Figure 18. Global Parkinson's Disease Therapeutics Market Share by Players in 2024
Figure 19. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Parkinson's Disease Therapeutics Revenue in 2024
Figure 21. North America Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Parkinson's Disease Therapeutics Market Share by Country (2020-2031)
Figure 23. United States Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Parkinson's Disease Therapeutics Market Share by Country (2020-2031)
Figure 27. Germany Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Parkinson's Disease Therapeutics Market Share by Region (2020-2031)
Figure 35. China Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Parkinson's Disease Therapeutics Market Share by Country (2020-2031)
Figure 43. Mexico Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Parkinson's Disease Therapeutics Market Share by Country (2020-2031)
Figure 47. Turkey Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Merck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 51. Akorn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 52. GSK Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 53. Novartis Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 54. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 55. Teva Pharmaceutical Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 56. Abbvie Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 57. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 58. Astellas Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 59. Roche Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 60. H.Lundbeck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 61. Bausch Health Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 62. Apokyn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 63. Orion Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 64. Stada Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 65. US WorldMeds Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 66. Desitin Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 67. Endo Pharmaceuticals Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Sinemet-CR
Table 3. Key Players of Trastal
Table 4. Key Players of Madopar
Table 5. Key Players of COMT Inhibitor
Table 6. Key Players of Other
Table 7. Global Parkinson's Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Parkinson's Disease Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Parkinson's Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Parkinson's Disease Therapeutics Market Share by Region (2020-2025)
Table 11. Global Parkinson's Disease Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Parkinson's Disease Therapeutics Market Share by Region (2026-2031)
Table 13. Parkinson's Disease Therapeutics Market Trends
Table 14. Parkinson's Disease Therapeutics Market Drivers
Table 15. Parkinson's Disease Therapeutics Market Challenges
Table 16. Parkinson's Disease Therapeutics Market Restraints
Table 17. Global Parkinson's Disease Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Parkinson's Disease Therapeutics Market Share by Players (2020-2025)
Table 19. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2024)
Table 20. Ranking of Global Top Parkinson's Disease Therapeutics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Parkinson's Disease Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Parkinson's Disease Therapeutics, Headquarters and Area Served
Table 23. Global Key Players of Parkinson's Disease Therapeutics, Product and Application
Table 24. Global Key Players of Parkinson's Disease Therapeutics, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Parkinson's Disease Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2020-2025)
Table 28. Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2026-2031)
Table 30. Global Parkinson's Disease Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2020-2025)
Table 32. Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2026-2031)
Table 34. North America Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Parkinson's Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Parkinson's Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Parkinson's Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Parkinson's Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Parkinson's Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 49. Merck Company Details
Table 50. Merck Business Overview
Table 51. Merck Parkinson's Disease Therapeutics Product
Table 52. Merck Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 53. Merck Recent Development
Table 54. Akorn Company Details
Table 55. Akorn Business Overview
Table 56. Akorn Parkinson's Disease Therapeutics Product
Table 57. Akorn Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 58. Akorn Recent Development
Table 59. GSK Company Details
Table 60. GSK Business Overview
Table 61. GSK Parkinson's Disease Therapeutics Product
Table 62. GSK Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 63. GSK Recent Development
Table 64. Novartis Company Details
Table 65. Novartis Business Overview
Table 66. Novartis Parkinson's Disease Therapeutics Product
Table 67. Novartis Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Boehringer Ingelheim Company Details
Table 70. Boehringer Ingelheim Business Overview
Table 71. Boehringer Ingelheim Parkinson's Disease Therapeutics Product
Table 72. Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 73. Boehringer Ingelheim Recent Development
Table 74. Teva Pharmaceutical Company Details
Table 75. Teva Pharmaceutical Business Overview
Table 76. Teva Pharmaceutical Parkinson's Disease Therapeutics Product
Table 77. Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 78. Teva Pharmaceutical Recent Development
Table 79. Abbvie Company Details
Table 80. Abbvie Business Overview
Table 81. Abbvie Parkinson's Disease Therapeutics Product
Table 82. Abbvie Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 83. Abbvie Recent Development
Table 84. Kyowa Hakko Kirin Pharma Company Details
Table 85. Kyowa Hakko Kirin Pharma Business Overview
Table 86. Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product
Table 87. Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 88. Kyowa Hakko Kirin Pharma Recent Development
Table 89. Astellas Pharma Company Details
Table 90. Astellas Pharma Business Overview
Table 91. Astellas Pharma Parkinson's Disease Therapeutics Product
Table 92. Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 93. Astellas Pharma Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Parkinson's Disease Therapeutics Product
Table 97. Roche Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 98. Roche Recent Development
Table 99. H.Lundbeck Company Details
Table 100. H.Lundbeck Business Overview
Table 101. H.Lundbeck Parkinson's Disease Therapeutics Product
Table 102. H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 103. H.Lundbeck Recent Development
Table 104. Bausch Health Company Details
Table 105. Bausch Health Business Overview
Table 106. Bausch Health Parkinson's Disease Therapeutics Product
Table 107. Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 108. Bausch Health Recent Development
Table 109. Apokyn Company Details
Table 110. Apokyn Business Overview
Table 111. Apokyn Parkinson's Disease Therapeutics Product
Table 112. Apokyn Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 113. Apokyn Recent Development
Table 114. Orion Company Details
Table 115. Orion Business Overview
Table 116. Orion Parkinson's Disease Therapeutics Product
Table 117. Orion Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 118. Orion Recent Development
Table 119. Stada Arzneimittel Company Details
Table 120. Stada Arzneimittel Business Overview
Table 121. Stada Arzneimittel Parkinson's Disease Therapeutics Product
Table 122. Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 123. Stada Arzneimittel Recent Development
Table 124. US WorldMeds Company Details
Table 125. US WorldMeds Business Overview
Table 126. US WorldMeds Parkinson's Disease Therapeutics Product
Table 127. US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 128. US WorldMeds Recent Development
Table 129. Desitin Arzneimittel Company Details
Table 130. Desitin Arzneimittel Business Overview
Table 131. Desitin Arzneimittel Parkinson's Disease Therapeutics Product
Table 132. Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 133. Desitin Arzneimittel Recent Development
Table 134. Endo Pharmaceuticals Company Details
Table 135. Endo Pharmaceuticals Business Overview
Table 136. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product
Table 137. Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 138. Endo Pharmaceuticals Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
Table 142. Authors List of This Report
List of Figures
Figure 1. Parkinson's Disease Therapeutics Picture
Figure 2. Global Parkinson's Disease Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Parkinson's Disease Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Sinemet-CR Features
Figure 5. Trastal Features
Figure 6. Madopar Features
Figure 7. COMT Inhibitor Features
Figure 8. Other Features
Figure 9. Global Parkinson's Disease Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Parkinson's Disease Therapeutics Market Share by Application: 2024 VS 2031
Figure 11. Under 40 Years Old Case Studies
Figure 12. 40-65 Years Old Case Studies
Figure 13. Above 65 Years Old Case Studies
Figure 14. Parkinson's Disease Therapeutics Report Years Considered
Figure 15. Global Parkinson's Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Parkinson's Disease Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Parkinson's Disease Therapeutics Market Share by Region: 2024 VS 2031
Figure 18. Global Parkinson's Disease Therapeutics Market Share by Players in 2024
Figure 19. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease Therapeutics as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Parkinson's Disease Therapeutics Revenue in 2024
Figure 21. North America Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Parkinson's Disease Therapeutics Market Share by Country (2020-2031)
Figure 23. United States Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Parkinson's Disease Therapeutics Market Share by Country (2020-2031)
Figure 27. Germany Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Parkinson's Disease Therapeutics Market Share by Region (2020-2031)
Figure 35. China Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Parkinson's Disease Therapeutics Market Share by Country (2020-2031)
Figure 43. Mexico Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Parkinson's Disease Therapeutics Market Share by Country (2020-2031)
Figure 47. Turkey Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Parkinson's Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Merck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 51. Akorn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 52. GSK Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 53. Novartis Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 54. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 55. Teva Pharmaceutical Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 56. Abbvie Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 57. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 58. Astellas Pharma Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 59. Roche Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 60. H.Lundbeck Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 61. Bausch Health Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 62. Apokyn Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 63. Orion Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 64. Stada Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 65. US WorldMeds Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 66. Desitin Arzneimittel Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 67. Endo Pharmaceuticals Revenue Growth Rate in Parkinson's Disease Therapeutics Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232